A randomized trial to assess effectiveness and cost in clinical practice: Rationale and design of the cholesterol reduction intervention study (CRIS)
Authors:
- Gerald M BorokGBGerald M Borok
- Joseph MenzinJMJoseph Menzin
- Joseph F HeyseJHJoseph F Heyse
- Robert S EpsteinRERobert S Epstein
- Virginia QuinnVQVirginia Quinn
- Victor BensonVBVictor Benson
- R.JAmes DudlRDR.JAmes Dudl
- Arnold EpsteinAEArnold Epstein
- 1 February 1995
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 16 (1) , 3-16
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Niacin revisited: Clinical observations on an important but underutilized drugThe American Journal of Medicine, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- The MOS Short-form General Health SurveyMedical Care, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJACC, 1986
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJAMA, 1986
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975